Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119272 · ClinicalTrials.gov registry record
Microbiome-mediated Weight, Anxiety, and Stress Dysregulation in Anorexia Nervosa
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 255
- Enrollment target
NCT03119272 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 255 participants.
The verdict
NCT03119272 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
The purpose of this research study is to analyze the microorganisms residing in the gut of patients with anorexia nervosa. Research has begun to link changes in the intestinal microbiota with diseases such as inflammatory bowel disease (IBS), asthma, and obesity, but although some studies have investigated the intestinal microbiota in overweight/obese individuals, very little is known about the intestinal microbiota in underweight individuals. The investigators aim to identify the enteric bacterial groups associated with adiposity, BMI, anxiety, and stress in patients with anorexia nervosa.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03119272
The ClinicalTrials.gov registry entry for NCT03119272 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03119272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03119272 about?
NCT03119272 is a clinical study titled "Microbiome-mediated Weight, Anxiety, and Stress Dysregulation in Anorexia Nervosa". The purpose of this research study is to analyze the microorganisms residing in the gut of patients with anorexia nervosa. Research has begun to link changes in the intestinal microbiota with diseases such as inflammatory bowel disease (IBS), asthma, and obesity, but although some studies have inves...
What is the current status of trial NCT03119272?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2016-04. Estimated completion is 2020-10.
Who is sponsoring clinical trial NCT03119272?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.